HC Wainwright & Co. initiated coverage on Lantern Pharma with a new price target

10/7/21 8:16:17 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. initiated coverage of Lantern Pharma with a rating of Buy and set a new price target of $32.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$LTRN

Date	Price Target	Rating	Analyst
3/11/2022	$34.00 → $36.00	Buy	HC Wainwright & Co.
11/2/2021	$32.00 → $34.00	Buy	HC Wainwright & Co.
10/7/2021	$32.00	Buy	HC Wainwright & Co.